MILLENNIUM MANAGEMENT LLC - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 336 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2017. The put-call ratio across all filers is 1.53 and the average weighting 0.2%.

Quarter-by-quarter ownership
MILLENNIUM MANAGEMENT LLC ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q2 2018$12,457,000
+57.7%
536,014
+8.0%
0.02%
+45.5%
Q1 2018$7,901,000
-10.4%
496,313
+16.9%
0.01%
-8.3%
Q4 2017$8,819,000
-67.5%
424,413
-77.6%
0.01%
-70.7%
Q3 2017$27,099,000
+105.7%
1,891,070
+148.4%
0.04%
+78.3%
Q2 2017$13,172,000
-28.0%
761,407
-54.1%
0.02%
-32.4%
Q1 2017$18,285,000
-5.7%
1,657,778
+24.1%
0.03%
-17.1%
Q4 2016$19,394,000
+331.1%
1,335,646
+628.8%
0.04%
+485.7%
Q3 2016$4,499,000
+170.2%
183,265
+121.7%
0.01%
+75.0%
Q2 2016$1,665,000
-63.1%
82,670
-51.8%
0.00%
-63.6%
Q1 2016$4,510,000
-74.6%
171,479
-1.7%
0.01%
-70.3%
Q4 2015$17,733,000
-62.0%
174,452
-33.3%
0.04%
-58.9%
Q3 2015$46,663,000
-79.9%
261,591
-75.0%
0.09%
-79.5%
Q2 2015$232,139,000
+27.1%
1,044,964
+13.7%
0.44%
+29.1%
Q1 2015$182,574,000
+8.4%
919,210
-21.9%
0.34%
-4.8%
Q4 2014$168,406,000
+280.1%
1,176,762
+248.5%
0.36%
+218.8%
Q3 2014$44,307,000
-51.1%
337,707
-53.0%
0.11%
-55.4%
Q2 2014$90,604,000
+16.1%
718,391
+21.4%
0.25%
+11.1%
Q1 2014$78,018,000
+6412.4%
591,804
+5702.0%
0.23%
+7433.3%
Q4 2013$1,198,000
+232.8%
10,200
+195.7%
0.00%
+200.0%
Q3 2013$360,000
-95.3%
3,450
-96.2%
0.00%
-95.8%
Q2 2013$7,721,00089,6900.02%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q4 2017
NameSharesValueWeighting ↓
ACCIPITER CAPITAL MANAGEMENT, LLC 2,106,379$55,398,00031.67%
Claren Road Asset Management, LLC 80,000$2,820,00024.27%
Okumus Fund Management Ltd. 3,722,464$97,901,00015.82%
Wingspan Investment Management, LP 852,900$22,431,00012.66%
FARLEY CAPITAL L.P. 307,458$8,086,00011.46%
Chou Associates Management 976,843$25,725,0008.35%
Wingspan Investment Management, LP 550,700$14,483,0008.17%
HAP Trading, LLC 4,043,900$109,610,0008.00%
LeVasseur Capital Partners LLC 128,269$3,373,0006.97%
Pershing Square Capital Management 21,591,122$567,847,0006.41%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders